The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report

Journal of Clinical Oncology

Volumn 27, Issue 2, 2009, Pages 298-303

  Monclair, Tom ^a   Brodeur, Garrett M ^b   Ambros, Peter F ^b   Brisse, Hervé J ^b   Cecchetto, Giovanni ^b   Holmes, Keith ^b   Kaneko, Michio ^b   London, Wendy B ^b   Matthay, Katherine K ^b   Nuchtern, Jed G ^b   Von Schweinitz, Dietrich ^b   Simon, Thorsten ^b   Cohn, Susan L ^b   Pearson, Andrew D J ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW METASTASIS; CANCER STAGING; CHILD; EVENT FREE SURVIVAL; FEMALE; HUMAN; INFANT; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SKIN METASTASIS; TUMOR CLASSIFICATION; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; INTERNATIONAL CLASSIFICATION OF DISEASES; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; SURVIVAL RATE;

CHILD; DISEASE-FREE SURVIVAL; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; NEUROBLASTOMA; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58249093954     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.6876     Document Type: Article

References (23)

1. Cohn SL, Pearson ADJ, London WB, et al: The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol [epub ahead of print on December 1, 2008]
2. Brodeur GM, Seeger RC, Barrett A, et al: International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881, 1988
3. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 11:1466-1477, 1993
4. Kushner BH, LaQuaglia MP, Kramer K, et al: Radically different treatment recommendations for newly diagnosed neuroblastoma: Pitfalls in assessment of risk. J Pediatr Hematol Oncol 26:35-39, 2004
5. Hero B, Simon T, Spitz R, et al: Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97. J Clin Oncol 26:1504-1510, 2008
6. Cecchetto G, Mosseri V, De Bernardi B, et al: Surgical risk factors in primary surgery for localized neuroblastoma: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 23:8483-8489, 2005
7. Holmes K, Mosseri V, Cecchetto, et al: Surgical risk factors (SRF) and outcome following primary surgery for localised neuroblastoma: Results of LNESG1. Pediatr Blood Cancer 49:433, 2007 (abstr O. 127)
8. Olivier P, Colarinha P, Fettich J, et al: Guidelines for radioiodinated MIBG scintigraphy in children. Eur J Nucl Med Mol Imaging 30:B45-B50, 2003
9. Simon T, Hero B, Benz-Bohm G, et al: Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Pediatr Blood Cancer 50:965-969, 2008
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J Royal Stat Soc A 135:185-198, 1972
12. Ikeda H, Iehara T, Tsuchida Y, et al: Experience with International Neuroblastoma Staging System and Pathology Classification. Br J Cancer 86:1110-1116, 2002
13. Rubie H, Hartmann O, Michon J, et al: N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. J Clin Oncol 15:1171-1182, 1997
14. Perez CA, Matthay KK, Atkinson JB, et al: Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study. J Clin Oncol 18:18-26, 2000
15. Evans AE, Silber JH, Shpilsky A, et al: Successful management of low-stage neuroblastoma without adjuvant therapies: A comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol 14:2504-2510, 1996
16. Matthay KK, Perez C, Seeger RC, et al: Successful treatment of stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study. J Clin Oncol 16:1256-1264, 1998
17. Berthold F, Simon T, Mertens R, et al: Children with metastatic neuroblastoma between 12 and 18 months of age may represent "Biological stage 4S". Presented at the Advances in Neuroblastoma Research Conference, Los Angeles, CA, May 17-20, 2006 (abstr 298)
18. Squire R, Sarnacki S, Haider N, et al: The outcome of surgical procedures at diagnosis in localised infant neuroblastoma, and the effect of chemotherapy on resectability: European infant neuroblastoma study. Pediatr Blood Cancer 49:402, 2007 (abstr O. 011)
19. Maris JM, Kyemba SM, Rebbeck TR, et al: Molecular genetic analysis of familial neuroblastoma. Eur J Cancer 33:1923-1928, 1997
20. Hiyama E, Yokoyama T, Hiyama K, et al: Multifocal neuroblastoma: Biological behavior and surgical aspects. Cancer 88:1955-1963, 2000
21. Cowie F, Corbett R, Ross Pinkerton C: Lung involvement in neuroblastoma: Incidence and characteristics. Med Pediatr Oncol 28:429-432, 1997
22. Kammen BF, Matthay KK, Pacharn P, et al: Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR 176:755-759, 2001
23. Gupta H, Conrad J, Khoury JD, et al: Significance of pleural effusion in neuroblastoma. Pediatr Blood Cancer 49:906-908, 2007